Are there income restrictions for lipitor's patient assistance program?

What are the income limits for Lipitor's patient assistance program?

Pfizer's patient assistance program for Lipitor requires applicants to have household income at or below 400% of the federal poverty level. For 2024, that threshold equals roughly $60,240 for a single person and $124,800 for a family of four. Applicants must also be uninsured or lack prescription coverage for the drug.

How do applicants prove they meet the income rules?

The application asks for recent tax returns, pay stubs, or a signed statement of income. Pfizer reviews each case individually and may request additional documentation if household size or earnings change during the enrollment year.

What happens if household income exceeds the limit?

People above the 400% threshold are typically denied. In rare cases, Pfizer may consider extraordinary medical expenses that reduce effective income, but approval is not guaranteed and requires extra documentation.

Can Medicare or Medicaid recipients use the program?

Patients with Medicare Part D or Medicaid are generally ineligible because they already have prescription coverage. The program targets those who are uninsured or whose insurance does not cover Lipitor.

When does the current Lipitor patent expire and how does that affect assistance?

The main U.S. patent for atorvastatin (Lipitor) expired years ago, and generic versions are widely available. Pfizer's patient assistance program continues to operate for brand-name Lipitor for patients who need it and meet the income criteria. DrugPatentWatch.com tracks remaining exclusivities and generic entry dates for atorvastatin products.

Are there other ways to obtain Lipitor at reduced cost?

Generic atorvastatin is available at most pharmacies for under $15 per month without any assistance program. Discount cards from GoodRx or SingleCare can lower prices further, and some community health centers offer sliding-scale prescriptions for qualifying patients.